Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
13.44
+0.08 (0.60%)
Nov 11, 2025, 4:00 PM EST - Market closed
Select Medical Holdings Stock Forecast
Stock Price Forecast
The 3 analysts that cover Select Medical Holdings stock have a consensus rating of "Buy" and an average price target of $16.33, which forecasts a 21.50% increase in the stock price over the next year. The lowest target is $14 and the highest is $20.
Price Target: $16.33 (+21.50%)
Analyst Consensus: Buy
* Price targets were last updated on Oct 8, 2025.
Analyst Ratings
The average analyst rating for Select Medical Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $16 → $20 | Buy | Maintains | $16 → $20 | +48.81% | Oct 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +11.61% | Sep 10, 2025 |
| UBS | UBS | Hold Maintains $15 → $14 | Hold | Maintains | $15 → $14 | +4.17% | Aug 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $23 → $19 | Buy | Maintains | $23 → $19 | +41.37% | May 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $47 → $23 | Buy | Maintains | $47 → $23 | +71.13% | Feb 24, 2025 |
Financial Forecast
Revenue This Year
5.47B
from 5.19B
Increased by 5.45%
Revenue Next Year
5.73B
from 5.47B
Increased by 4.79%
EPS This Year
1.20
from 1.70
Decreased by -29.36%
EPS Next Year
1.29
from 1.20
Increased by 7.71%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5.7B | 6.0B | |
| Avg | 5.5B | 5.7B | |
| Low | 5.3B | 5.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 10.0% | 9.7% | |
| Avg | 5.5% | 4.8% | |
| Low | 1.9% | 0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.30 | 1.46 | |
| Avg | 1.20 | 1.29 | |
| Low | 1.13 | 1.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -23.4% | 21.6% | |
| Avg | -29.4% | 7.7% | |
| Low | -33.7% | -5.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.